The Signaling Pathway of the ADP Receptor P2Y12 in the Immune System: Recent Discoveries and New Challenges
International Journal of Molecular Sciences · 04.04.2023 · 24 (7) · 6709
DOI: 10.3390/ijms24076709 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.04.2023. Verfasst von Philomena Entsie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo, ND 58105, USA. Hauptthemen laut MEDLINE: COVID-19, Receptors, Purinergic P2. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Health, German Research Foundation (DFG) CRC1423.
Abstract (Originalsprache)
P2Y12 is a G-protein-coupled receptor that is activated upon ADP binding. Considering its well-established role in platelet activation, blocking P2Y12 has been used as a therapeutic strategy for antiplatelet aggregation in cardiovascular disease patients. However, receptor studies have shown that P2Y12 is functionally expressed not only in platelets and the microglia but also in other cells of the immune system, such as in monocytes, dendritic cells, and T lymphocytes. As a result, studies were carried out investigating whether therapies targeting P2Y12 could also ameliorate inflammatory conditions, such as sepsis, rheumatoid arthritis, neuroinflammation, cancer, COVID-19, atherosclerosis, and diabetes-associated inflammation in animal models and human subjects. This review reports what is known about the expression of P2Y12 in the cells of the immune system and the effect of P2Y12 activation and/or inhibition in inflammatory conditions. Lastly, we will discuss the major problems and challenges in studying this receptor and provide insights on how they can be overcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo, ND 58105, USA.
- Division of Molecular Biochemistry, Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, Leipzig University, 04103 Leipzig, Germany.
ORCID-Profile: Philomena Entsie, Torsten Schöneberg, Elisabetta Liverani
Förderung
- NIAID NIH HHS
- National Institute of Health
- German Research Foundation (DFG) CRC1423
- American Heart Association
- Monika Putscher
Zitieren
APA
Entsie, P., Kang, Y., Amoafo, E. B., Schöneberg, T., & Liverani, E. (2023). The Signaling Pathway of the ADP Receptor P2Y12 in the Immune System: Recent Discoveries and New Challenges. International Journal of Molecular Sciences, 24(7), 6709. https://doi.org/10.3390/ijms24076709
Vancouver
Entsie P, Kang Y, Amoafo EB, Schöneberg T, Liverani E. The Signaling Pathway of the ADP Receptor P2Y12 in the Immune System: Recent Discoveries and New Challenges. International Journal of Molecular Sciences. 2023;24(7):6709. doi:10.3390/ijms24076709
BibTeX
@article{Entsie2023,
author = {Entsie, Philomena and Kang, Ying and Amoafo, Emmanuel Boadi and Schöneberg, Torsten and Liverani, Elisabetta},
title = {The Signaling Pathway of the ADP Receptor P2Y12 in the Immune System: Recent Discoveries and New Challenges},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {7},
pages = {6709},
doi = {10.3390/ijms24076709}
}
EUVIMED